Palonosetron versus ondansetron in CINV (chemotherapy-induced nausea and vomiting)

被引：0
|
作者：
Vieira, S. [1 ]
Monroe, D. [1 ]
Sorita, R. [1 ]
Palomar, M. [1 ]
Librojo, M. [1 ]
Porin, L. [1 ]
Ng, J. [1 ]
Taylor, A. [1 ]
机构：
[1] Trustee London Clin, London, England
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Palonosetron Versus Ondansetron in Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Children
    Chaudhary, N.
    Boddu, D.
    John, R. R.
    Gowri, M. S.
    Nesadeepam, W. N.
    Mathew, L. G.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S17 - S17
  • [2] Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Lee Schwartzberg
    Sally Y. Barbour
    Gary R. Morrow
    Gianluca Ballinari
    Michael D. Thorn
    David Cox
    Supportive Care in Cancer, 2014, 22 : 469 - 477
  • [3] Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Schwartzberg, Lee
    Barbour, Sally Y.
    Morrow, Gary R.
    Ballinari, Gianluca
    Thorn, Michael D.
    Cox, David
    SUPPORTIVE CARE IN CANCER, 2014, 22 (02) : 469 - 477
  • [4] Palonosetron versus ondansetron as prophylaxis of chemotherapy-induced nausea and vomiting: a single-centre experience
    Tendas, A.
    Niscola, P.
    Cupelli, L.
    Trawinska, M. M.
    Abruzzese, E.
    Siniscalchi, A.
    Caravita, T.
    Scaramucci, L.
    Giovannini, M.
    Angelini, S.
    Perrotti, A. P.
    Dentamaro, T.
    Arcese, W.
    De Fabritiis, P.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S174 - S174
  • [5] Dronabinol or ondansetron alone and combined for delayed chemotherapy-induced nausea and vomiting (CINV).
    Jhangiani, H
    Vredenburgh, JJ
    Barbato, L
    Yang, HC
    Yang, HM
    Baranowski, V
    Tse, N
    BLOOD, 2005, 106 (11) : 477B - 477B
  • [6] Analysis of phase III clinical studies for palonosetron, ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV).
    Barbour, S. Y.
    Morrow, G. R.
    Ahmed, R.
    Ballinari, G.
    Thorn, M. D.
    Cox, D.
    Schwartzberg, L. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Clonazepam for chemotherapy-induced nausea and vomiting (CINV)
    Koga, Minako
    Nakadozono, Momoe
    Nukariya, Kazutaka
    Nogi, Hiroko
    Kobayashi, Tadashi
    Nakayama, Kazuhiko
    ANTICANCER RESEARCH, 2008, 28 (4C) : 2433 - 2436
  • [8] Palonosetron for the prevention of chemotherapy-induced nausea and vomiting
    Mori-Vogt, Sherry
    Blazer, Marlo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (08) : 919 - 936
  • [9] Palonosetron for the treatment of chemotherapy-induced nausea and vomiting
    Navari, Rudolph M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (17) : 2599 - 2608
  • [10] ONDANSETRON VERSUS GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
    FEDELE, P
    SPINA, M
    VALENTINI, M
    COLLINI, D
    LUCIA, C
    MANICONE, M
    TIRELLI, U
    CANCER, 1995, 76 (03) : 535 - 536
12345